Author Archive
Meg Kramer
Meg Kramer is a writer and editor who has covered topics in science, health, and education.
When she's not writing about CBD, you can find her playing with her dogs or perfecting her bagel recipe.
With the resignation of Attorney General Jeff Sessions this week, hemp and medical cannabis advocates are hoping for a friendlier face to step into the role. Sessions
For decades, nutritionists have known that olive oil can provide serious health benefits as part of a healthy diet. And in their “Hemp and Olive” line of
Epidiolex, the first cannabis-derived medicine that the FDA has ever approved, is now available in pharmacies in the United States. This follows the DEA’s limited rescheduling of
Can non-cannabis plants produce the compounds known as cannabinoids? Some researchers say yes. The latest contender for an alternate plant source of cannabinoids is liverwort.
Let’s start by getting this week’s biggest cannabis story out of the way: yes, Canada legalized it! And for our friends in the north, Bloomberg put together
Are you an adventurous CBD consumer who demands quality, variety, and top-notch customer service? Of course you are. And that’s why we’d like to introduce you to
The World Health Organization’s (WHO) Expert Committee on Drug Dependence (ECDD) will consider reclassifying cannabis when they meet in Geneva next month. And as part of this
In this week’s top CBD story, the FDA memo recommending that CBD be categorized as a Schedule V controlled substance was made public. And it contained a
What do you do when you’re a new CBD company and you’re looking for ways to stand out from the competition? Well, if you’re Fab CBD, you
In this week’s biggest CBD news development, the Drug Enforcement Agency has rescheduled FDA-approved drugs containing CBD:
SHARE
This Week in CBD: November 9, 2018